Boston Scientific Targets Multi-Billion Hypertension Market With SoniVie Acquisition
Full Deal Values Company At $540m
Boston Scientific has entered the multi-billion hypertension treatment market with the acquisition of Israel-based startup SoniVie, developer of the TIVUS intravascular ultrasound system for the treatment of high blood pressure by artery nerve ablation.
